CashKaro co-founder says she had kidney transplant during Series C raise
In short
Swati Bhargava said she had a kidney transplant while CashKaro was raising money for its Series C round. The fundraising was for ₹130 crore.
What the reporting says
Swati Bhargava said she underwent a kidney transplant while CashKaro was raising funds for its Series C round. The disclosure links a major fundraising effort with a serious personal health battle during the same period. The account highlights the timing of the company’s capital raise and Bhargava’s recovery.
Why it matters
Swati Bhargava revealed that she underwent a kidney transplant while CashKaro was raising funds for its Series C round. The disclosure ties a ₹130 crore fundraising effort to a difficult period for the company’s co-founder. The story is about the founder’s personal health situation alongside a startup financing event.